Medplus Health Services (NSE:MEDPLUS) Debt-to-Equity: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDPLUS Medplus Health Services Ltd NSE:MEDPLUS
76 GF Score
Price ₹660.65
GF Value ₹974.08
Valuation Significantly Undervalued
View Full Analysis

What is Medplus Health Services Debt-to-Equity?

Medplus Health Services's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. Medplus Health Services's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. Medplus Health Services's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medplus Health Services's Debt-to-Equity or its related term are showing as below:

NSE:MEDPLUS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.54   Med: 0.64   Max: 1.47
Current: 0.72

During the past 8 years, the highest Debt-to-Equity Ratio of Medplus Health Services was 1.47. The lowest was 0.54. And the median was 0.64.

NSE:MEDPLUS's Debt-to-Equity is ranked worse than
63.77% of 563 companies
in the Healthcare Providers & Services industry
Industry Median: 0.43 vs NSE:MEDPLUS: 0.72

Medplus Health Services  (NSE:MEDPLUS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medplus Health Services Debt-to-Equity Related Terms

Medplus Health Services Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Medplus Health Services's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medplus Health Services Debt-to-Equity Chart

Medplus Health Services Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial 0.58 0.60 0.64 0.64 0.72

Medplus Health Services Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.65 N/A 0.72 N/A

Medplus Health Services Debt-to-Equity Competitor Comparison

For the Pharmaceutical Retailers subindustry, Medplus Health Services's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medplus Health Services Debt-to-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medplus Health Services's Debt-to-Equity falls into.


NSE:MEDPLUS
76GF Score
Medplus Health Services Ltd NSE:MEDPLUS
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medplus Health Services Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medplus Health Services's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1912.59 + 12331.24) / 19753.59
=0.72

Medplus Health Services's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?

Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued. The current stock price of ₹660.65 is trading 32.2% below its estimated GF Value™ of ₹974.08. GuruFocus considers Medplus Health Services to be Significantly Undervalued.

Key valuation signals for NSE:MEDPLUS:

  • Debt-to-Equity: N/A
  • GF Value™: ₹974.08 vs. price of ₹660.65 (32.2% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medplus Health Services Business Description

Other Exchanges 543427:India
Address Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
76GF Score

Get the complete analysis for NSE:MEDPLUS

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹660.65
Price
₹974.08
GF Value